EGFR mutations in squamous cell lung cancer in never-smokers

J Thorac Oncol. 2013 Jan;8(1):e6-7. doi: 10.1097/JTO.0b013e3182762d49.

Authors

Christina S Baik¹, Colin C Pritchard, Keith D Eaton, Laura Q Chow

Affiliation

¹ Thoracic, Head and Neck Program, Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington, USA. cbaik2@u.washington.edu

PMID: 23242446
DOI: 10.1097/JTO.0b013e3182762d49

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / genetics*
Adenocarcinoma / pathology
Carcinoma, Squamous Cell / drug therapy
Carcinoma, Squamous Cell / genetics*
Carcinoma, Squamous Cell / secondary*
Epidural Neoplasms / secondary
Epidural Neoplasms / therapy
ErbB Receptors / genetics*
Erlotinib Hydrochloride
Female
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Middle Aged
Mutation
Pleural Effusion, Malignant / genetics
Pleural Effusion, Malignant / pathology*
Protein Kinase Inhibitors / therapeutic use
Quinazolines / therapeutic use
Smoking
Thoracic Vertebrae

Substances

Protein Kinase Inhibitors
Quinazolines
Erlotinib Hydrochloride
ErbB Receptors